Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of Results

11th Aug 2017 07:00

RNS Number : 7518N
Georgia Healthcare Group PLC
11 August 2017
 

  London, 11 August 2017

 

 

 

 

Georgia Healthcare Group PLC notice of 2Q and 1H 2017 Results

 

Georgia Healthcare Group PLC ("GHG") will publish its financial results for 2Q and 1H 2017 at 07:00 London time on Tuesday, 15 August 2017. The results announcement will be available on GHG's website at ghg.com.ge. An investor/analyst conference call, organised by GHG, will be held on Tuesday, 15 August 2017, at 14:00 UK / 15:00 CET / 09:00 U.S Eastern Time. The duration of the call will be 60 minutes and will consist of a 15-minute update and a 45-minute Q&A session.

 

Dial-in numbers:

30-Day replay

Pass code for replays / conference ID: 68385863

Pass code for replays / conference ID: 68385863

International Dial in: + 44 (0) 2071 928000

International Dial in: +44 (0) 1452 55 00 00

UK: 08445718892

UK National Dial in: 08717000145

US: 16315107495

UK Local Dial in: 08443386600

Austria: 019286559

US Free Call Dial in: 1 (866) 247 4222

Belgium: 024009874

Czech Republic: 228881424

Denmark: 32728042

Finland: 0942450806

France: 0176700794

Germany: 030221531802

Hungary: 0614088064

Ireland: 014319615

Italy: 0687502026

Luxembourg: 27860515

Netherlands: 0207143545

Norway: 23960264

Spain: 914146280

Sweden: 0850692180

Switzerland: 0315800059

 

Name of authorised official of issuer responsible for making notification:

Ketevan Kalandarishvili, Head of Investor Relations

 

About Georgia Healthcare Group PLC

Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 35 hospitals and ten ambulatory clusters (consisting of 13 district ambulatory clinics and 28 express ambulatory clinics), as at 31 March 2017. GHG is the single largest market participant, accounting for 23.4% of total hospital bed capacity in the country, as of 31 March 2017. From January 2017, GHG become the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 29% market share based on 31 December 2015 revenue figures. GHG is also the largest provider of medical insurance in Georgia with a 35.3% market share based on net insurance premiums earned and approximately 135,000 insurance customers as at 31 March 2017. GHG employed a total of c.14,600 people as at 31 March 2017, including c.3,300 physicians.

 

For further information, please visit www.ghg.com.ge or contact: 

Nikoloz Gamkrelidze

Irakli Gogia

Ketevan Kalandarishvili

CEO

CFO

Head of Investor Relations

+995 322 550505 (5077)

+995 322 550505 (5088)

+995 322 550505 (5079)

[email protected]

[email protected]

[email protected]

 

 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOREFLBFDVFXBBQ

Related Shares:

GHG.L
FTSE 100 Latest
Value8,275.66
Change0.00